Electrophysiologic Results After Thoracoscopic Ablation for Chronic Atrial Fibrillation

被引:31
|
作者
On, Young Keun
Park, Kyoung-Min
Jeong, Dong Seop
Park, Pyo Won
Lee, Young Tak
Park, Seung-Jung
Kim, June Soo
机构
[1] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Div Cardiol,Dept Med, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Thorac & Cardiovasc Surg,Heart Stroke Vasc I, Seoul 135710, South Korea
关键词
PULMONARY VEIN ISOLATION; FOLLOW-UP; MAZE; MANAGEMENT; ARRHYTHMIA; CONDUCTION; CATHETER;
D O I
10.1016/j.athoracsur.2015.04.127
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Thoracoscopic ablation for lone atrial fibrillation (AF) has evolved rapidly in the past decade. We investigated the electrophysiologic results and midterm durability of totally thoracoscopic ablation in patients with lone persistent AF. Methods. Seventy-nine consecutive patients with paroxysmal AF (8 patients, 10.1%), persistent AF (17 patients, 21.5%), and long-standing persistent AF (54 patients, 68.3%) were prospectively enrolled. Thoracoscopic ablation consisted of a bilateral closed-chest approach to performing pulmonary isolation (a box lesion), ganglionated plexus ablation, division of the Marshall ligament, and left atrial auricle resection. An electrophysiologic study was performed 5 days after the surgical procedure in 61 patients (77%). Freedom from AF was assessed with electrocardiograms or Holter monitoring every 3 months, with a mean follow-up of 12.1 (maximum, 28) months. Results. No deaths or conversion to cardiopulmonary bypass occurred. During electrophysiologic study, 28 residual pulmonary vein potentials were observed in 15 patients (19%). Out of a total of 28 gaps, 20 (71%) were located in the superior and inferior ridges of pulmonary veins. Six gaps (21%) were detected in the carina of pulmonary veins. The mitral isthmus was ablated in 2 patients (7%). Freedom from AF at 2 years was 92.6 +/- 3.3%. Freedom from cardiac-related events at 2 years was 74.7 +/- 6.0%. Cox regression analysis demonstrated that the predictors of atrial arrhythmias were old age, hypertension, and left atrial volume index. Conclusions. Thoracoscopic ablation followed by electrophysiologic confirmation was safe and provided excellent midterm durability in patients with AF. However, the incidence of residual potentials around the pulmonary veins was not negligible. (C) 2015 by The Society of Thoracic Surgeons
引用
收藏
页码:1595 / 1603
页数:9
相关论文
共 50 条
  • [21] Readmissions and repeat procedures after catheter ablation for atrial fibrillation
    Opolski, Grzegorz
    Januszkiewicz, Lukasz
    Szczerba, Ewa
    Osinska, Boguslawa
    Rutkowski, Daniel
    Kalarus, Zbigniew
    Kazmierczak, Jaroslaw
    CARDIOLOGY JOURNAL, 2015, 22 (06) : 630 - 636
  • [22] Thoracoscopic surgical atrial fibrillation ablation in patients with an extremely enlarged left atrium
    Neefs, Jolien
    Wesselink, Robin
    van den Berg, Nicoline W. E.
    de Jong, Jonas S. S. G.
    Piersma, Femke R.
    van Boven, WimJan P.
    Driessen, Antoine H. G.
    de Groot, Joris R.
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 2022, 64 (02) : 469 - 478
  • [23] Minimally invasive surgical atrial fibrillation ablation: Patient selection and results
    Han, Frederick T.
    Kasirajan, Vigneshwar
    Wood, Mark A.
    Ellenbogen, Kenneth A.
    HEART RHYTHM, 2009, 6 (12) : S71 - S76
  • [24] Catheter Ablation for Atrial Fibrillation
    Thomas, Stuart P.
    Sanders, Prashanthan
    HEART LUNG AND CIRCULATION, 2012, 21 (6-7) : 395 - 401
  • [25] Hybrid Thoracoscopic Surgical and Transvenous Catheter Ablation of Atrial Fibrillation
    Pison, Laurent
    La Meir, Mark
    van Opstal, Jurren
    Blaauw, Yuri
    Maessen, Jos
    Crijns, Harry J.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (01) : 54 - 61
  • [26] Midterm results of stand-alone thoracoscopic epicardial ablation with box lesion for atrial fibrillation
    Yu, Chunyu
    Li, Haojie
    Zhang, Heng
    Zheng, Zhe
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2021, 33 (03) : 354 - 361
  • [27] Totally thoracoscopic ablation for atrial fibrillation: a systematic safety analysis
    Vos, Lara M.
    Kotecha, Dipak
    Geuzebroek, Guillaume S. C.
    Hofman, Frederik N.
    van Boven, Wim Jan P.
    Kelder, Johannes
    de Mol, Bas A. J. M.
    van Putte, Bart P.
    EUROPACE, 2018, 20 (11): : 1790 - 1797
  • [28] Novel P Wave Indices to Predict Atrial Fibrillation Recurrence After Radiofrequency Ablation for Paroxysmal Atrial Fibrillation
    Hu, Xiaoliang
    Jiang, Jingzhou
    Ma, Yuedong
    Tang, Anli
    MEDICAL SCIENCE MONITOR, 2016, 22 : 2616 - 2623
  • [29] Catheter ablation for chronic atrial fibrillation
    Michael R. Gold
    Current Cardiology Reports, 2006, 8 (5) : 313 - 314
  • [30] Results of the first investigator-initiated randomized clinical trial of nMARQ™, PVAC™, and thoracoscopic ablation for paroxysmal atrial fibrillation
    Sugihara, Conn
    Furniss, Steve
    Hyde, Jonathan
    Lewis, Michael
    Sulke, Neil
    EUROPACE, 2018, 20 : F384 - F391